WO2007086898A3 - Methods and compositions related to anthrax spore glycoproteins - Google Patents

Methods and compositions related to anthrax spore glycoproteins Download PDF

Info

Publication number
WO2007086898A3
WO2007086898A3 PCT/US2006/012329 US2006012329W WO2007086898A3 WO 2007086898 A3 WO2007086898 A3 WO 2007086898A3 US 2006012329 W US2006012329 W US 2006012329W WO 2007086898 A3 WO2007086898 A3 WO 2007086898A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
glycoproteins
anthrax
disclosed
compositions related
Prior art date
Application number
PCT/US2006/012329
Other languages
French (fr)
Other versions
WO2007086898A2 (en
Inventor
Alvin Fox
Karen Fox
Michael J Stump
Erin Worthy
Lashanda Waller
Original Assignee
Univ South Carolina
Alvin Fox
Karen Fox
Michael J Stump
Erin Worthy
Lashanda Waller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Carolina, Alvin Fox, Karen Fox, Michael J Stump, Erin Worthy, Lashanda Waller filed Critical Univ South Carolina
Publication of WO2007086898A2 publication Critical patent/WO2007086898A2/en
Publication of WO2007086898A3 publication Critical patent/WO2007086898A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed are compositions and methods relating to the anthrax spore glycoproteins of Bacillus anthracis. Disclosed are the methods of using these compositions for vaccination against anthrax infection. Disclosed are BclA and BclB, components of anthrax spores, which can be used, either alone or in combination, as an antigen for eliciting protective immunity against anthrax.
PCT/US2006/012329 2005-03-31 2006-03-31 Methods and compositions related to anthrax spore glycoproteins WO2007086898A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66693905P 2005-03-31 2005-03-31
US60/666,939 2005-03-31

Publications (2)

Publication Number Publication Date
WO2007086898A2 WO2007086898A2 (en) 2007-08-02
WO2007086898A3 true WO2007086898A3 (en) 2007-11-08

Family

ID=38309647

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/012329 WO2007086898A2 (en) 2005-03-31 2006-03-31 Methods and compositions related to anthrax spore glycoproteins

Country Status (1)

Country Link
WO (1) WO2007086898A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133251B2 (en) * 2008-02-22 2015-09-15 The Curators Of The University Of Missouri Bacillus based delivery system and methods of use
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
GB2525177A (en) * 2014-04-14 2015-10-21 New Royal Holloway & Bedford Vaccine
CA2961641A1 (en) 2014-09-17 2016-03-24 Spogen Biotech Inc. Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STEICHEN C. ET AL.: "Identification of the immunodominant protein and other proteins of the Bacillus anthracis exosporium", J. BACTERIOL., vol. 185, no. 6, March 2003 (2003-03-01), pages 1903 - 1910 *

Also Published As

Publication number Publication date
WO2007086898A2 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
WO2007024941A3 (en) Polyvalent vaccine
WO2007030810A3 (en) Multiparameter whole blood monitor and method
WO2009016639A3 (en) Multimeric multiepitope influenza vaccines
TW200740458A (en) Vaccination against dengue virus infection
WO2004075829A3 (en) Adjuvanted influenza vaccine
WO2009114207A3 (en) Replication-defective flavivirus vaccines and vaccine vectors
WO2006081259A3 (en) Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
WO2006091722A3 (en) Alkyl-glycoside enhanced vaccination
WO2010019262A3 (en) Polyvalent vaccine
WO2006076003A3 (en) Vaccinia virus strains
WO2008054481A3 (en) Improved inactivated influenza virus compositions
WO2007006712A3 (en) Mycoplasma subunit vaccine
WO2006055024A3 (en) Minicells as vaccines
MX2011007456A (en) Cna_b domain antigens in vaccines against gram positive bacteria.
WO2009081274A3 (en) Mutant forms of streptolysin o
WO2008048344A3 (en) Bacillus anthracis antigens, vaccine compositions, and related methods
WO2010053610A3 (en) Stable anthrax vaccine formulations
MX2012004622A (en) Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof.
WO2006078975A3 (en) Improved vaccine against feline calicivirus
WO2007086898A3 (en) Methods and compositions related to anthrax spore glycoproteins
WO2010046061A3 (en) Cosmetic and/or pharmaceutical formulations
WO2007044607A3 (en) Methods and compositions relating to anthrax spore glycoproteins as vaccines
WO2009105192A3 (en) Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax
WO2007120603A3 (en) Immunogenic bcr-abl peptides and methods of use thereof

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06849749

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 06849749

Country of ref document: EP

Kind code of ref document: A2